Breast Cancer Treatment with Afinitor® (Everolimus) and Exemestane for HR+ Women (BRAWO)

16/04/2015
02/07/2024
EU PAS number:
EUPAS9462
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol_final_BRAWO_CRAD001JDE53_Amendment 6 20151011_Redacted

English (421.26 KB - PDF) View document
Study results
Study results

2018-11-16_CSR_BRAWO Final Report Redacted

English (1.09 MB - PDF) View document
Study report
Other information